Live
Endpoints NewsShanghai biotech Excalipoint gains $68.7M for T cell engagersBioPharma DiveChinese biotech startup Excalipoint banks $69M for next-gen T cell engagersWatersGraybill Wealth Management LTD. Makes New Investment in Waters Corporation $WAT - MarketBeatAgilentIs It Time To Reassess Agilent Technologies (A) After Its Recent Share Price Weakness - Yahoo Finance SingaporeEndpoints NewsXaira unveils AI model X-Cell for predicting virtual cellsThermo FisherThermo Fisher Scientific Inc. $TMO Shares Purchased by CIBC Private Wealth Group LLC - MarketBeatAgilentAgilent’s $950m Biocare buy: The ‘aligned’ asset for pathology innovation - BioXconomyThermo FisherThermo Fisher: A High-Quality Life Science Platform Positioned For Growth (NYSE:TMO) - Seeking AlphaAgilentAssessing Agilent Technologies (A) Valuation After Recent Share Price Weakness - Yahoo FinanceIlluminaLife Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders - TradingVieweLifeAn easy way to improve lab meetingseLifeFunctional connectivity-based attractor dynamics of the human brain in rest, task, and disease
Endpoints News Jan 30, 2026

FDA says it explained issues early on for Corcept's rejected Cushing's syndrome drug

FDA says it explained issues early on for Corcept's rejected Cushing's syndrome drug

Original
Body unavailable. Use the original source.

Directory

59 All